Happening now at #AACR26: Charles Sawyers, MD (
@MSKCancerCenter
) discusses how cancer cells evade targeted therapies through shifts in cell lineage, highlighting new challenges and opportunities for precision oncology.

Key takeaways:
•Adenocarcinomas with RB1 loss are at risk